 2  4 
occasionally aggregated in the alveolar interstitium in the ACE2-HB-01 mice, by contrast, 1 0 9 they were rarely observed in the WT-HB-01 mice ( Supplementary Figure 2b) .
Perivascular infiltrated inflammatory cells, including lymphocytes and monocytes, were 1 1 1 observed multifocally within and adjacent to affected areas of the lungs. At 5 dpi, the 1 1 2 lung progressed into coalescing interstitial pneumonia with diffuse lesions. Thickened 1 1 3 alveolar septa were filled with lymphocytes and monocytes (Figure 2a ). IHC staining of 1 1 4 sequential section revealed that viral antigens were found in the alveolar macrophages, 1 1 5 alveolar epithelia, and the degenerative and being desquamated bronchial epithelial cells 1 1 6 ( Figure 2b ). There were no significant histopathological lesions ( Supplementary Figure 3 or viral antigens of SARS-CoV-2 ( Supplementary Figure 4) in the other organs, including 1 1 8 myocardium, liver, spleen, kidney, cerebrum, intestine, and testis. At 7 dpi, the 1 1 9 pneumonia became mild with focal lesion areas (data not shown). In addition, the co-localization of SARS-CoV-2 S protein (Fifure 3f) and hACE2 the SARS-CoV-2, as same as SARS-CoV, also utilizes the hACE2 as a receptor for 1 2 5 entry 4 . The speed of geographical spread of COVID-19 caused by SARS-CoV-2 has been 1 2 7 declared as public health emergency of international concern (PHEIC), with cases 1 2 8 reported on multiple continents only weeks after the disease was first reported 6 . Although 1 2 9 it has been determined by bioinformatics that the pathogen of this epidemic is a novel 1 3 0 coronavirus, it is necessary to be confirmed by animal experiments following Koch's In the present study, after the experimental infection of hACE2 transgenic mice with 1 3 3 one of the earliest known isolates of SARS-CoV-2, the mice lost weight and showed 1 3 4 interstitial pneumonia, which are comparable with initial clinical reports of pneumonia The case fatality rate of currently reported cases is about 2%, which implies that so 1 4 4 far, this novel coronavirus does not seem to cause the high fatality rates as SARS-CoV 1 4 5 (9-11%) 9 , which suggested the difference in pathogenicity between the two viruses. The 1 4 6 pathogenicity of SARS-CoV-2 seems mild compared to SARS-CoV in mice, the latter 1 4 7 caused extrapulmonary organ damage, includes brain, kidney, intestine, heart and liver, and hemorrhage were observed in hACE2 transgenic mice 10,11 . However, only interstitial Therefore, our results clarified the pathogenicity of SARS-CoV-2 in mice, together Murine studies were performed in an animal biosafety level 3 (ABSL3) facility using 1 6 0 HEPA-filtered isolators. All procedures in this study involving animals were reviewed Center (accession number NMDC10013001 and genome accession numbers 100 IU/ml penicillin, and 100 µg/ml streptomycin, and incubated at 37°C, 5% CO 2 . For infected mice, the lung homogenates were used for virus titration tests using endpoint 50% tissue culture infection dose (TCID50) assay. For the animal experiments, specific pathogen-free, 6-11-month-old, male and female 1 8 0 transgenic hACE2 mice were obtained from the Institute of Laboratory Animal Science, into the pronuclei of fertilized ova from ICR mice, and then human ACE2 integrated was identified by PCR as previous described 10 , the hACE2 mainly expressed in lung, heart, mice were dissected at 1 dpi 3 dpi, 5 dpi and 7 dpi respectively to collect different tissues 1 9 1 to screen virus replication and histopathological changes. Tissues homogenates were prepared by homogenizing perfused whole tissue using an 1 9 5 electric homogenizer for 2 min 30 s in 1 ml of DMEM. The homogenates were 1 9 6 centrifuged at 3,000 rpm for 10 min at 4°C. The supernatant was collected and stored at 1 9 7 −80°C for viral isolation and viral load detection. processed in duplicate using the following cycling protocol: 50°C for 2 min, 95°C for 2 2 0 6 min, followed by 40 cycles at 95°C for 15 s and 60°C for 30 s, and then 95°C for 15 s, TCGTTTCGGAAGAGACAGGT-3', Reverse: 5'-GCGCAGTAAGGATGGCTAGT-3'. The PCR products were verified by sequencing using the dideoxy method on an ABI 2 1 1 3730 DNA sequencer (Applied Biosystems, CA, USA). During the sequencing process, 2 1 2 amplification was performed using specific primers. The sequences for this process are the results were compared using the Megalign module in the DNAStar software package. The specific IgG against SARS-CoV from ACE2-HB-01 mice and WT-HB-01 mice were tested sera were diluted at 1:100 and added to each well, and 3 multiple wells were set for 2 2 1 each sample, and then incubated at 37℃ for 30 minutes, followed by the goat anti-mouse 2 2 2 secondary antibodies conjugated with HRP ( ZB-2305, zhongshan,1:10,000 dilution), and 2 2 3 incubated at room temperature for 30 minutes. The reaction was developed by TMB 2 2 4 substrate and the optical densities at 450 nm were determined (Metertech960 enzyme 2 2 5 marker with 450 nm wavelength). Laboratory preparation of the antibody of SARS-CoV-2 Spike-1 (S1) protein 2 2 8
Mice were immunized with purified SARS-CoV-2 S1 protein (Sino biological) and 2 2 9 splenocytes of hyper immunized mice were fused with myeloma cells. Positive clones 2 3 0 were selected by ELISA using SARS-CoV-2 S1 protein ( Supplementary Figure 1) . The 2 3 1 cell supernatant of 7D2 clone, binding to SARS-CoV-2 S1 protein, was collected for 2 3 2 immunofluorescence analysis. The organs were fixed in 10% buffered formalin solution, and paraffin sections (3-4 µm 2 4 4 in thickness) were prepared routinely. Sections were treated with an antigen retrieval kit 2 4 5 (Boster, AR0022) for 1 min at 37℃ and quenched for endogenous peroxidases in 3% 2 4 6 H 2 O 2 in methanol for 10 min. After blocking in 1% normal goat serum, the sections were 2 4 7 incubated with 7D2 monoclonal antibody (laboratory preparation) at 4℃ overnight, Biotechnology, ZDR-5307). Alternatively, the sections were stained with MAC2 and mounted on a slide and viewed under an Olympus microscope. For viruses and hACE2 receptor co-localization analysis, the lung tissue sections were 2 6 0 washed twice with PBS, fixed by Immunol Staining Fix Solution (P0098), blocked 1 hour 2 6 1 at room temperature by Immunol Staining Blocking Buffer (P0102) and then incubated 2 6 2 overnight at 4°C with the appropriate primary and secondary antibodies. The nuclei were 
